A
Atropos Health
Rapidly provides personalized real-world evidence for any clinical decision
About Atropos Health
Atropos Health operates in the healthcare technology sector, focusing on providing personalized real world evidence to physicians. The company addresses the 'Evidence Gap' in clinical research, which arises when randomized control trials (RCTs) exclude significant patient populations. Atropos Health's core product is a digital consultation service that leverages observational research and proprietary technology developed over five years at Stanford University. This service enables physicians to answer complex clinical questions within 24 hours by rapidly querying patient data. The business model is based on offering subscription-based access to its consultation services, targeting healthcare providers, hospitals, and research institutions. Revenue is generated through these subscriptions and potentially through partnerships with pharmaceutical companies and other stakeholders in the healthcare ecosystem.
Source: Dealroom company dataNews
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | May 2024 | $33M | $132M | Presidio Ventures · McKesson Ventures · Emerson Collective · Valtruis | ↗ |
| EARLY VC✓Equity / VC | Sep 2023 | $0 | — | Presidio Ventures · Gaingels · Audere Capital · Samsung Next | ↗ |
Growth signals
Latest recorded traffic for Atropos Health is 7.3K monthly website visits, down 22.3% over the last three months. Atropos Health's team grew 3.4% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Atropos Health in the New York City ecosystem
The Atropos Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A11 investors entered at this stage
Breyer Capital
Emerson Collective- BPBoston Millennia Partners
Presidio Ventures
Gaingels
Audere Capital
Samsung Next
McKesson Ventures
Valtruis
Merck Global Health Innovation Fund- CVCencora Ventures
Other known investors1 additional known investor
Touchdown Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Atropos Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Atropos Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








